Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidative stress pathway modulation refers to the regulation of cellular processes that control the balance between the production of reactive oxygen species (ROS) and antioxidant defenses. Oxidative stress occurs when this balance is disrupted, leading to excessive ROS that can damage proteins, lipids, and DNA. This imbalance is implicated in a wide range of pathological conditions including inflammation, apoptosis (programmed cell death), cancer, neurodegenerative diseases, cardiovascular diseases, diabetes, immune dysfunctions, and aging. Key components include ROS, antioxidant enzymes (SOD, GPX, CAT), non-enzymatic antioxidants (glutathione, vitamins), the NRF2-KEAP1 pathway, and the NF-κB pathway.
Varies depending on the specific drug. Includes: activation of NRF2, inhibition of ROS production, direct scavenging of ROS.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative Stress Pathway Modulation.